greater danger of small blood sugar (hypoglycemia) in patients with type two diabetes, especially those that also acquire medicines for type 2 diabetes including sulfonylureas or insulin. This may be both equally a significant and common side impact. Discuss with your healthcare service provider regarding how to acknowledge and treat minimal blood